Sisu Global Hemafuse

Sisu Global Health

Hemafuse is a handheld tool for autotransfusion.

Product description Brand name and product description

The Sisu Global Hemafuse is a manual autotransfusion device is that used to retransfuse a patient’s own blood during an internal hemorrhage. The Hemafuse is in early-stage development and undergoing field trials.

Target region(s) Target region for distribution/implementation (listed by country if specified)

Sub-Saharan Africa countries- Ghana, Rwanda, Kenya, Tanzania, and Ethiopia

Distributors/implementing organizations Organization(s) distributing/deploying this product directly to communities/individuals?"

Hospitals, NGO, governments will buy Sisu Global Hemafuse from Sisu and distribute.

Market suggested retail price Price per unit or service price per usage/terms (USD). Subsidies noted.

The Hemafuse body is projected to cost $50 retail for 50 uses. Each filter is designed to cost $10 retail, and is disposable after each patient. The cost for these filters will be passed onto the patient or to the national health insurance scheme

Competitive landscape Similar products available on the market. May not be a comprehensive listing.

Direct transfusion via widely used manual procedure commonly used in Sub-Saharan Africa which consists of salvaging blood with a kitchen soup ladle and filtering it with gauze, Cell processors and salvage devices. Devices include: Transmed Transfusion DevicesCell Saver®, Medtronic autoLog, & Beldico Transfusion set.

SDG targeted United Nations Sustainable Development Goals (SDGs) targeted with this product/application/service

Goal 3: Ensure Healthy lives and promote well-being for all at all ages

Target user(s) Target user/consumer base (country, income segment)
The @AutodeskFdn blogged about our how-to guide for communities writing proposals for development projects